Please note Epocrates will no longer provide this CME offering after December 31, 2015. However this free offering will continue to be available directly from RealCME and there will be no interruption to your account, including credits, certificates and new course offerings.

Please directly access your account by clicking RealCME Health Professional and use the same email address to log in to your account that you have used with EpocratesCME. For security purposes, you will be asked to establish a new password.

Promoting Recovery in Schizophrenia: A Focus on Positive and Negative Symptoms - Patient Follow-Up


Promoting Recovery in Schizophrenia: A Focus on Positive and Negative Symptoms - Patient Follow-Up

Topic: Psychiatry
Relevant Terms: Schizophrenia
Primary Audience: Psychiatrists, Psychiatry Nurse Practioners
Launch Date: 14-Jan-14
Credits: 0.5 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Promoting Recovery in Schizophrenia: A Focus on Positive and Negative Symptoms

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Describe, evaluate, and diagnose positive and negative symptoms of schizophrenia
  2. Recognize long-term consequences and functional implications of positive and negative symptoms
  3. Describe the efficacy and safety of existing and emerging agents in the treatment of schizophrenia, with regard to treating both positive and negative symptoms
  4. Implement psychosocial interventions and mechanisms for educating patients and caregivers regarding both positive and negative symptoms of schizophrenia and their functional impact


    Christoph U. Correll, MD
    Medical Director, Recognition and Prevention (RAP) Program
    The Zucker Hillside Hospital
    Investigator, Feinstein Institute for Medical Research
    Associate Professor of Psychiatry
    Hofstra North Shore LIJ School of Medicine
    Adjunct Associate Professor of Psychiatry
    Albert Einstein College of Medicine
    Glen Oaks, NY
    Robert W. Buchanan, MD
    Professor, Department of Psychiatry
    University of Maryland School of Medicine
    Maryland Psychiatric Research Center
    Baltimore, MD
    Stephen R. Marder, MD
    Director, Section on Psychosis
    Professor, Psychiatry and Biobehavioral Sciences
    David Geffen School of Medicine
    Professor in Residence, Semel Institute
    University of California, Los Angeles
    Los Angeles, CA
    Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
    Faculty Disclosures
    • Christoph U. Correll, MD, has affiliations with Actelion, Alexza; Bristol-Myers Squibb, Cephalon, Eli Lilly, Genentech, Gerson Lehrman Group, IntraCellular Therapies, Janssen/J&J, Lundbeck, Medavante, Medscape, Merck, Otsuka, Pfizer, ProPhase, Roche, Sunovion, Takeda, Teva, and Vanda (Consultant); Merck (non-promotional lecture only) (Speaker's Bureau); BMS, Janssen/J&J, and Otsuka (Research).
    • Robert W. Buchanan, MD, has affiliations with Abbott, Amgen, Bristol-Meyers-Squibb; En Vivo; Omeros; Roche (Consultant); Pfizer (Other: Data Safety Monitoring Board).
    • Stephen R. Marder, MD, has affiliations with Pfizer, Genentech, Abbott, Boeringer-Ingelheim, Lundbeck, BMS, Otsuka, Shire, Roche, Targacept (Consultant); Amgen, Sunovion (Research); MedAvante (Stockholder).
    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    • Jacqui Brooks, MBBCh, MRCPsych has no affiliations with commercial interests to disclose.
    • Cindy Kunzer has no affiliations with commercial interests to disclose.
    Postgraduate Institute for Medicine
    The following PIM staff serve as clinical content reviewers and/or participate in planning CME/CE activities in a manner that may affect content:, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME/CE activity of any amount during the past 12 months.

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and RMEI, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

    The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Estimated time to complete: 30 minutes
    Medium: Internet

    There is no fee for this educational activity.

    This activity is jointly sponsored by RMEI, LLC and Postgraduate Institute for Medicine. RMEI gratefully acknowledges an educational grant from Genentech in support of this CME activity.

    By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 0.5 AMA PRA Category 1 Credits™. A statement of credit will be available to print from your user history page.
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit. You must score with a 65% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 5.0+ for Mac OSX 10.5 and above

    For video playback, install the latest version of Flash or Quicktime.
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above